Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma

Emil Lou; Katherine B. Peters; Ashley L. Sumrall; Annick Desjardins; David A. Reardon; Eric S. Lipp; James E. Herndon; April Coan; Leighann Bailey; Scott Turner; Henry S. Friedman; James J. Vredenburgh

doi:10.1002/cam4.58

Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma

Emil Lou
, Katherine B. Peters
, Ashley L. Sumrall
, Annick Desjardins
, David A. Reardon
, Eric S. Lipp
, James E. Herndon
, April Coan
, Leighann Bailey
, Scott Turner
, Henry S. Friedman
, James J. Vredenburgh

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	185-195
Journal	Cancer medicine
Volume	2
Issue number	2
DOIs	https://doi.org/10.1002/cam4.58 https://doi.org/10.1002/cam4.2013.2.issue-2
State	Published - Apr 1 2013

Publisher link

10.1002/cam4.58License: CC BY
10.1002/cam4.2013.2.issue-2

https://onlinelibrary.wiley.com/doi/10.1002/cam4.58

Find It

Find It at U of M Libraries

Cite this

Lou, E., Peters, K. B., Sumrall, A. L., Desjardins, A., Reardon, D. A., Lipp, E. S., Herndon, J. E., Coan, A., Bailey, L., Turner, S., Friedman, H. S., & Vredenburgh, J. J. (2013). Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma. Cancer medicine, 2(2), 185-195. https://doi.org/10.1002/cam4.58, https://doi.org/10.1002/cam4.2013.2.issue-2

Lou, E, Peters, KB, Sumrall, AL, Desjardins, A, Reardon, DA, Lipp, ES, Herndon, JE, Coan, A, Bailey, L, Turner, S, Friedman, HS & Vredenburgh, JJ 2013, 'Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma', Cancer medicine, vol. 2, no. 2, pp. 185-195. https://doi.org/10.1002/cam4.58, https://doi.org/10.1002/cam4.2013.2.issue-2

@article{f9ec6ebe5d79402f82d1625b6d5b011f,

title = "Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma",

author = "Emil Lou and Peters, \{Katherine B.\} and Sumrall, \{Ashley L.\} and Annick Desjardins and Reardon, \{David A.\} and Lipp, \{Eric S.\} and Herndon, \{James E.\} and April Coan and Leighann Bailey and Scott Turner and Friedman, \{Henry S.\} and Vredenburgh, \{James J.\}",

year = "2013",

month = apr,

day = "1",

doi = "10.1002/cam4.58",

language = "English (US)",

volume = "2",

pages = "185--195",

journal = "Cancer medicine",

issn = "2045-7634",

publisher = "John Wiley and Sons Inc.",

number = "2",

}

TY - JOUR

T1 - Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma

AU - Lou, Emil

AU - Peters, Katherine B.

AU - Sumrall, Ashley L.

AU - Desjardins, Annick

AU - Reardon, David A.

AU - Lipp, Eric S.

AU - Herndon, James E.

AU - Coan, April

AU - Bailey, Leighann

AU - Turner, Scott

AU - Friedman, Henry S.

AU - Vredenburgh, James J.

PY - 2013/4/1

Y1 - 2013/4/1

U2 - 10.1002/cam4.58

DO - 10.1002/cam4.58

M3 - Article

SN - 2045-7634

VL - 2

SP - 185

EP - 195

JO - Cancer medicine

JF - Cancer medicine

IS - 2

ER -